Literature DB >> 12170103

Alcohol and benzodiazepines in fatal poisonings.

Anna Koski1, Ilkka Ojanperä, Erkki Vuori.   

Abstract

BACKGROUND: Postmortem forensic toxicology frequently finds alcohol both alone and in combination with drugs. Although benzodiazepines are generally considered safe, they are considered dangerous with alcohol.
METHODS: A retrospective statistical analysis of alcohol and benzodiazepine concentrations in postmortem blood samples included 808 cases diagnosed as fatal alcohol or drug intoxication involving (1) ethanol alone; (2) ethanol with temazepam; or (3) ethanol with any combination of diazepam, chlordiazepoxide, and nordazepam.
RESULTS: The median concentration of ethanol was 3.3 per thousand in cases with ethanol alone and 3.5 per thousand when diazepam was present, but it was significantly lower, only 2.5 per thousand, when temazepam was present in the blood. Furthermore, the median concentration of ethanol was 2.2 per thousand in cases with high concentrations (>0.9 mg/liter) of temazepam and 2.7 per thousand in cases with therapeutic (< or =0.9 mg/liter) concentrations.
CONCLUSIONS: Diazepam and chlordiazepoxide pose a smaller risk of death by poisoning than does temazepam when given as a hypnotic to patients suffering from alcoholism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12170103     DOI: 10.1097/01.ALC.0000021337.78063.67

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  13 in total

Review 1.  Neuroimaging insights into the role of cortical GABA systems and the influence of nicotine on the recovery from alcohol dependence.

Authors:  Kelly P Cosgrove; Irina Esterlis; Graeme F Mason; Frederic Bois; Stephanie S O'Malley; John H Krystal
Journal:  Neuropharmacology       Date:  2011-01-27       Impact factor: 5.250

2.  The relationship between past-year drinking behaviors and nonmedical use of prescription drugs: prevalence of co-occurrence in a national sample.

Authors:  Sean Esteban McCabe; James A Cranford; Carol J Boyd
Journal:  Drug Alcohol Depend       Date:  2006-04-18       Impact factor: 4.492

3.  Simultaneous and concurrent polydrug use of alcohol and prescription drugs: prevalence, correlates, and consequences.

Authors:  Sean Esteban McCabe; James A Cranford; Michele Morales; Amy Young
Journal:  J Stud Alcohol       Date:  2006-07

4.  Loop 2 structure in glycine and GABA(A) receptors plays a key role in determining ethanol sensitivity.

Authors:  Daya I Perkins; James R Trudell; Daniel K Crawford; Liana Asatryan; Ronald L Alkana; Daryl L Davies
Journal:  J Biol Chem       Date:  2009-08-05       Impact factor: 5.157

5.  Prevalence of adverse drug combinations in a large post-mortem toxicology database.

Authors:  Terhi Launiainen; Erkki Vuori; Ilkka Ojanperä
Journal:  Int J Legal Med       Date:  2008-06-27       Impact factor: 2.686

Review 6.  Can cannabis be considered a substitute medication for alcohol?

Authors:  Meenakshi Sabina Subbaraman
Journal:  Alcohol Alcohol       Date:  2014-01-08       Impact factor: 2.826

7.  Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data.

Authors:  Anna Koski; Erkki Vuori; Ilkka Ojanperä
Journal:  Int J Legal Med       Date:  2005-03-01       Impact factor: 2.686

8.  Medical use, illicit use, and diversion of abusable prescription drugs.

Authors:  Sean Esteban McCabe; Christian J Teter; Carol J Boyd
Journal:  J Am Coll Health       Date:  2006 Mar-Apr

9.  Coadministration of disulfiram and lorazepam in the treatment of alcohol dependence and co-occurring anxiety disorder: an open-label pilot study.

Authors:  Michael P Bogenschutz; Snehal Bhatt; Juliane Bohan; Bellelizabeth Foster; Paul Romo; Claire E Wilcox; J Scott Tonigan
Journal:  Am J Drug Alcohol Abuse       Date:  2016-05-16       Impact factor: 3.829

Review 10.  GABAA receptor subtypes: the "one glass of wine" receptors.

Authors:  Richard W Olsen; Harry J Hanchar; Pratap Meera; Martin Wallner
Journal:  Alcohol       Date:  2007-05       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.